Heather Payne

机构：The Prostate Centre · ORCID：0000-0001-8117-7411

发表论文 102 篇 · 总被引 1277 次 · h-index 14

代表论文

• Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial (2023 · The Lancet Oncology · 被引 198)
• An immune dysfunction score for stratification of patients with acute infection based on whole-blood gene expression (2022 · Science Translational Medicine · 被引 110)
• Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial (NCT00541047) (2024 · Annals of Oncology · 被引 53)
• Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial (2024 · The Lancet · 被引 51)
• The Role of Multiparametric MRI and MRI–targeted Biopsy in the Diagnosis of Radiorecurrent Prostate Cancer: An Analysis from the FORECAST Trial (2023 · European Urology · 被引 26)
• Geographic, socioeconomic and demographic inequalities in the incidence of metastatic prostate cancer at time of diagnosis in England: a population-based evaluation (2025 · BMJ Oncology · 被引 10)